These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 19372056
1. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sañudo A, Antunes AA, Srougi M. Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056 [Abstract] [Full Text] [Related]
2. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R. Clin Cancer Res; 2011 Aug 15; 17(16):5287-98. PubMed ID: 21159887 [Abstract] [Full Text] [Related]
3. miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. Fendler A, Jung M, Stephan C, Honey RJ, Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K, Yousef GM. Int J Oncol; 2011 Nov 15; 39(5):1183-92. PubMed ID: 21769427 [Abstract] [Full Text] [Related]
4. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Cancer Res; 2010 Jan 01; 70(1):36-45. PubMed ID: 20028859 [Abstract] [Full Text] [Related]
5. The microRNA profile of prostate carcinoma obtained by deep sequencing. Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. Mol Cancer Res; 2010 Apr 01; 8(4):529-38. PubMed ID: 20353999 [Abstract] [Full Text] [Related]
6. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H. Prostate; 2013 Jun 01; 73(8):827-34. PubMed ID: 23184537 [Abstract] [Full Text] [Related]
7. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M. Am J Pathol; 2012 May 01; 180(5):1808-15. PubMed ID: 22426337 [Abstract] [Full Text] [Related]
8. Detection of microRNAs in prostate cancer cells by microRNA array. Tang X, Tang X, Gal J, Kyprianou N, Zhu H, Tang G. Methods Mol Biol; 2011 May 01; 732():69-88. PubMed ID: 21431706 [Abstract] [Full Text] [Related]
9. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M. Int J Oncol; 2011 Aug 01; 39(2):409-15. PubMed ID: 21567082 [Abstract] [Full Text] [Related]
10. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing. Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau TT, Hartmann A, Grässer FA, Wullich B. Mol Cancer Res; 2014 Feb 01; 12(2):250-63. PubMed ID: 24337069 [Abstract] [Full Text] [Related]
11. MicroRNA expression profiles in human colorectal cancers with liver metastases. Lin M, Chen W, Huang J, Gao H, Ye Y, Song Z, Shen X. Oncol Rep; 2011 Mar 01; 25(3):739-47. PubMed ID: 21174058 [Abstract] [Full Text] [Related]
12. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA. Mol Cancer Res; 2011 Jun 01; 9(6):791-800. PubMed ID: 21593139 [Abstract] [Full Text] [Related]
13. MicroRNA profile analysis of human prostate cancers. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. Cancer Gene Ther; 2009 Mar 01; 16(3):206-16. PubMed ID: 18949015 [Abstract] [Full Text] [Related]
14. MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, Srougi M. Urol Oncol; 2013 Aug 01; 31(6):796-801. PubMed ID: 21880514 [Abstract] [Full Text] [Related]
15. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. Biomed Pharmacother; 2010 Jul 01; 64(6):399-408. PubMed ID: 20363096 [Abstract] [Full Text] [Related]
16. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O. Cancer Res; 2011 Mar 01; 71(5):1956-67. PubMed ID: 21343391 [Abstract] [Full Text] [Related]
17. The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer. Reis ST, Timoszczuk LS, Pontes-Junior J, Viana N, Silva IA, Dip N, Srougi M, Leite KR. Clinics (Sao Paulo); 2013 May 01; 68(5):652-7. PubMed ID: 23778407 [Abstract] [Full Text] [Related]